MYTESI (Napo Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the MYTESI drug offered from Napo Pharmaceuticals, Inc.. This Antidiarrheal [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Napo Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | Crofelemer |
| SUBSTANCE NAME: | CROFELEMER |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Antidiarrheal [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2016-08-01 |
| END MARKETING DATE: | 0000-00-00 |
MYTESI HUMAN PRESCRIPTION DRUG Details:
| Item Description | MYTESI from Napo Pharmaceuticals, Inc. |
| LABELER NAME: | Napo Pharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 125(mg/1) |
| START MARKETING DATE: | 2016-08-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 70564-802_1f132951-84d1-4e66-b647-675befa443e6 |
| PRODUCT NDC: | 70564-802 |
| APPLICATION NUMBER: | NDA202292 |
Other CROFELEMER Pharmaceutical Manufacturers / Labelers:
